financetom
Business
financetom
/
Business
/
Tejon Ranch Shares Fall After Q1 Swing to Loss, Lower Revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tejon Ranch Shares Fall After Q1 Swing to Loss, Lower Revenue
May 7, 2024 10:51 AM

01:33 PM EDT, 05/07/2024 (MT Newswires) -- Tejon Ranch ( TRC ) shares fell 3% in recent Tuesday trading, after the company swung to a loss and lower revenue in Q1.

The company reported a Q1 loss of $0.03 per diluted share, compared with earnings of $0.07 per share a year earlier.

One analyst surveyed by Capital IQ expected earnings of $0.08.

Revenue for the quarter ended March 31 was $7.4 million, down from $12.3 million a year earlier.

One analyst surveyed by Capital IQ expected $12.5 million.

Price: 16.13, Change: -0.52, Percent Change: -3.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Columbia Basin Ice LLC and Oregon Ice LLC Acquire Reddy Ice Assets in the Pacific Northwest
Columbia Basin Ice LLC and Oregon Ice LLC Acquire Reddy Ice Assets in the Pacific Northwest
Mar 11, 2026
Customers Assured of Seamless Service KENNEWICK, Wash., March 3, 2026 /PRNewswire/ -- Columbia Basin Ice LLC, in partnership with Oregon Ice LLC, today announced the successful acquisition of select manufacturing, distribution, and customer assets formerly operated by Reddy Ice across Washington, Oregon, and Idaho. The transaction became effective February 19, 2026, and includes production facilities, transportation equipment, and established customer...
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
Mar 11, 2026
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced its official launch following a period of stealth operations. The company is emerging with a Phase 1b/2a-ready clinical asset and the first close of its Seed financing. As part of its launch, Persevere has acquired the clinical-stage program and related...
Copyright 2023-2026 - www.financetom.com All Rights Reserved